| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/21/2010 | WO2010009433A1 Modified release formulation and methods of use |
| 01/21/2010 | WO2010009428A1 Trioxane dimer sulfur compounds |
| 01/21/2010 | WO2010009405A2 Targeted nitroxide agents |
| 01/21/2010 | WO2010009389A1 Use of targeted nitroxide agents in preventing, mitigating and treating radiation injury |
| 01/21/2010 | WO2010009369A2 Methods and materials for the treatment of acne |
| 01/21/2010 | WO2010009342A2 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors |
| 01/21/2010 | WO2010009334A1 Method for preparing largazole analogs and uses thereof |
| 01/21/2010 | WO2010009332A1 Binding and inhibiting 5-ht4 receptor |
| 01/21/2010 | WO2010009327A1 Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| 01/21/2010 | WO2010009309A1 Pharmaceutical formulations containing dopamine receptor ligands |
| 01/21/2010 | WO2010009290A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | WO2010009288A1 Compositions and uses of antiviral active pharmaceutical agents |
| 01/21/2010 | WO2010009285A1 Use of hdac inhibitors for the treatment of acute myeloid leukemia and/or myelodysplastic syndrome |
| 01/21/2010 | WO2010009280A1 Use of hdac inhibitors for the treatment of hodgkin's disease |
| 01/21/2010 | WO2010009215A1 Nicotinic acid receptor agonist compounds useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009212A1 Niacin derivatives useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009208A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 01/21/2010 | WO2010009207A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 01/21/2010 | WO2010009197A1 Solid forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol and methods of their use |
| 01/21/2010 | WO2010009195A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 01/21/2010 | WO2010009194A1 Methods of treating atherosclerosis |
| 01/21/2010 | WO2010009183A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | WO2010009166A1 Oxindolyl inhibitor compounds |
| 01/21/2010 | WO2010009155A2 Fused heterocyclyc inhibitor compounds |
| 01/21/2010 | WO2010009139A2 Imidazolyl pyrimidine inhibitor compounds |
| 01/21/2010 | WO2010009120A2 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |
| 01/21/2010 | WO2010009116A2 Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents |
| 01/21/2010 | WO2010009075A1 Methods and compositions comprising crystalline nanoparticles of hydrophobic compounds |
| 01/21/2010 | WO2010009069A1 Chromene modulators of chemokine receptor activity |
| 01/21/2010 | WO2010009068A2 Cyclohexenyl modulators of chemokine receptor activity |
| 01/21/2010 | WO2010009065A2 Amphipathic peptide compositions |
| 01/21/2010 | WO2010009062A1 Imidazole carboxamides |
| 01/21/2010 | WO2010009056A2 Pain relieving patch |
| 01/21/2010 | WO2010009047A1 Pyridone derivatives as non-nucleoside reverse transcriptase inhibitors |
| 01/21/2010 | WO2010009038A2 Antisense formulation |
| 01/21/2010 | WO2010009014A2 Antibiotic drug |
| 01/21/2010 | WO2010008976A2 Combined calcium, magnesium and vitamin d supplements |
| 01/21/2010 | WO2010008894A1 Benzyloxy anilide derivatives useful as potassium channel modulators |
| 01/21/2010 | WO2010008864A2 Cycloalkane[b]indole angtagonists of prostaglandin d2 receptors |
| 01/21/2010 | WO2010008852A2 Methods of trea fing λλd methods of diagnosing an immunoproliferative disorder |
| 01/21/2010 | WO2010008843A1 Apoptosis signal-regulating kinase 1 inhibitors |
| 01/21/2010 | WO2010008832A1 Pyrrolo-pyridine-3-yl-piperazine derivatives having 5-ht6 receptor affinity |
| 01/21/2010 | WO2010008792A1 Nanoparticles for use as synthetic platelets and therapeutic agent delivery vehicles |
| 01/21/2010 | WO2010008776A2 Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems |
| 01/21/2010 | WO2010008775A1 Aminopyridopyrazinone derivatives for treating neurodegenerative diseases |
| 01/21/2010 | WO2010008761A1 Piperidyl acrylamide antogonists of ccr2 |
| 01/21/2010 | WO2010008746A1 Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues |
| 01/21/2010 | WO2010008744A2 Antineoplastic combinations containing hki-272 and vinorelbine |
| 01/21/2010 | WO2010008739A2 Aryl gpr119 agonists and uses thereof |
| 01/21/2010 | WO2010008735A2 Solid states of o-desmethylvenlaf axine salts |
| 01/21/2010 | WO2010008734A2 Methods of Preparing Imidazole-Based Bicyclic Compounds |
| 01/21/2010 | WO2010008733A2 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/21/2010 | WO2010008731A1 Methods for determining sensitivity to aminoflavones |
| 01/21/2010 | WO2010008727A1 Asymmetric synthesis of allyl or allene oxindoles |
| 01/21/2010 | WO2010008719A2 Oral pharmaceutical formulations of vla-4 antagonists |
| 01/21/2010 | WO2010008619A2 Extended release pharmaceutical formulations of s-adenosylmethionine |
| 01/21/2010 | WO2010008601A1 Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic |
| 01/21/2010 | WO2010008594A1 Method of treating traumatic brain injury |
| 01/21/2010 | WO2010008569A1 Orally disintegrating solid pharmaceutical dosage forms comprising delayed-release lansoprazole and methods of making and using the same |
| 01/21/2010 | WO2010008558A1 Compounds and methods of inducing apoptosis via interaction with chaperonin cct |
| 01/21/2010 | WO2010008554A2 Methods and products for treating proliferative diseases |
| 01/21/2010 | WO2010008521A1 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| 01/21/2010 | WO2010008504A1 Preventing the occurrence of obesity |
| 01/21/2010 | WO2010008491A2 Lactose compositions with decreased lactose content |
| 01/21/2010 | WO2010008473A1 Enzyme inhibitors and the use thereof |
| 01/21/2010 | WO2010008459A1 Protein kinase inhibitors |
| 01/21/2010 | WO2010008454A1 Protein kinase inhibitors |
| 01/21/2010 | WO2010008341A1 A combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist |
| 01/21/2010 | WO2010008317A1 Agent for activating stem cells |
| 01/21/2010 | WO2010008312A1 Antihypertensive 1-alkyl-2-alkylcarbamoyl-glycerins and a method of the production thereof |
| 01/21/2010 | WO2010008299A1 Novel sulphur containing lipids for use as food supplement or as medicament |
| 01/21/2010 | WO2010008263A1 Use of thalidomide to inhibit the osteoclast-activation process associated with multiple myeloma disease |
| 01/21/2010 | WO2010008135A1 Oral soft capsule of aceclofenac having improved stability |
| 01/21/2010 | WO2010008129A1 Composition containing decursin or decursinol angelate for treating angiogenesis-related diseases |
| 01/21/2010 | WO2010008114A1 Anti-cancer composition comprising microrna molecules |
| 01/21/2010 | WO2010008084A1 Novel use application of sugar chain-recognizing receptor |
| 01/21/2010 | WO2010008069A1 Cell proliferation inhibitor |
| 01/21/2010 | WO2010008001A1 Aptamer against il-17 and use thereof |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007966A1 Azole compound |
| 01/21/2010 | WO2010007944A1 Nitrogenated bicyclic heterocyclic compound |
| 01/21/2010 | WO2010007943A1 Nitrogenated heterocyclic compound |
| 01/21/2010 | WO2010007800A1 Novel uracil compound having amide structure and salt thereof |
| 01/21/2010 | WO2010007794A1 Novel spiro compound, and pharmaceutical preparation comprising the same |
| 01/21/2010 | WO2010007788A1 Glycyrrhetinic acid derivative and use thereof |
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | WO2010007701A1 Therapeutic agent and test agent for disease with myocardial necrosis |
| 01/21/2010 | WO2010007651A1 Composition having anti-periodontal disease effect |
| 01/21/2010 | WO2010007631A1 New composition for treating autoimmune disorders |
| 01/21/2010 | WO2010007629A1 A kit comprising anti-emetic and oral contraceptive |
| 01/21/2010 | WO2010007626A1 A method of synthesizing a substantially monodispersed mixture of oligomers |
| 01/21/2010 | WO2010007622A2 Long-acting interferons and derivatives thereof and methods thereof |
| 01/21/2010 | WO2010007561A1 Novel compounds active as muscarinic receptor antagonists |
| 01/21/2010 | WO2010007552A1 Novel compounds active as muscarinic receptor antagonists |
| 01/21/2010 | WO2010007530A1 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| 01/21/2010 | WO2010007522A1 Rna antagonists targeting gli2 |
| 01/21/2010 | WO2010007482A2 Thiazole derivatives as stearoyl coa desaturase inhibitors |
| 01/21/2010 | WO2010007427A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | WO2010007389A1 5 -amidothiazole derivatives and their use as checkpoint kinase inhibitors |
| 01/21/2010 | WO2010007387A1 Process for producing glycosaminoglycans |